p53 directly suppresses the expression and translocation of glucose transporter 1 (GLUT1) and GLUT4 [38] and indirectly downregulates GLUT3 [39] to reduce glucose uptake from the tumor microenvironment. The gene discussed is SLC2A1; the disease is neoplasm.